CI-994 in Treating Patients With Advanced Myeloma
NCT00005624
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
6
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
CI-994
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Collaborators
[object Object]
[object Object]